| scholarly article | Q13442814 |
| P2093 | author name string | Fiona Oakley | |
| Derek A. Mann | |||
| Grant A. Ramm | |||
| Richard G. Ruddell | |||
| Irene Yeung | |||
| Lesley J. Bryan-Lluka | |||
| Ziafat Hussain | |||
| P2860 | cites work | Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization | Q24308751 |
| Ritanserin as an adjunct to lithium and haloperidol for the treatment of medication-naive patients with acute mania: a double blind and placebo controlled trial | Q24800266 | ||
| Molecular, pharmacological and functional diversity of 5-HT receptors | Q28206145 | ||
| Phosphatidylinositol-3 kinase and extracellular signal-regulated kinase mediate the chemotactic and mitogenic effects of insulin-like growth factor-I in human hepatic stellate cells | Q28372756 | ||
| Insulin-like growth factor (IGF)-binding protein-1 is highly induced during acute carbon tetrachloride liver injury and potentiates the IGF-I-stimulated activation of rat hepatic stellate cells | Q28581666 | ||
| 5-HT2B receptor-mediated serotonin morphogenetic functions in mouse cranial neural crest and myocardiac cells | Q28588283 | ||
| Liver fibrosis | Q29547449 | ||
| Activation of 5-HT receptors that stimulate the adenylyl cyclase pathway positively regulates IGF-I in cultured craniofacial mesenchymal cells. | Q31927550 | ||
| Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury | Q33822590 | ||
| SNaRIs, NaSSAs, and NaRIs: new agents for the treatment of depression | Q33884433 | ||
| Changes in plasma serotonin concentration and acceleration plethysmograms in patients with Raynaud's phenomenon after long-term treatment with a 5-HT2 receptor antagonist | Q33926187 | ||
| Induction of beta-platelet-derived growth factor receptor in rat hepatic lipocytes during cellular activation in vivo and in culture | Q34190381 | ||
| Developmentally regulated serotonin 5-HT2B receptors. | Q34264903 | ||
| Extracellular matrix degradation and the role of hepatic stellate cells | Q34391375 | ||
| Transcriptional regulation of hepatic stellate cell activation | Q34637612 | ||
| PDGF and signal transduction in hepatic stellate cells | Q34754831 | ||
| Nitric oxide donors inhibit 5-hydroxytryptamine (5-HT) uptake by the human 5-HT transporter (SERT). | Q35047597 | ||
| 5-hydroxytryptamine 2B receptor regulates cell-cycle progression: cross-talk with tyrosine kinase pathways | Q35077547 | ||
| Serotonin mechanisms in heart valve disease I: serotonin-induced up-regulation of transforming growth factor-beta1 via G-protein signal transduction in aortic valve interstitial cells | Q35748222 | ||
| Molecular and functional characterization of proteins interacting with the C-terminal domains of 5-HT2 receptors: emergence of 5-HT2 "receptosomes". | Q35811309 | ||
| Cloning and expression of a functional serotonin transporter from rat brain | Q38332277 | ||
| Cloning and expression of the mouse serotonin transporter | Q39758098 | ||
| Activated stellate cells express the TRAIL receptor-2/death receptor-5 and undergo TRAIL-mediated apoptosis. | Q40681279 | ||
| Regulation of serotonin transporter gene expression in human glial cells by growth factors | Q40812966 | ||
| Hepatocytes express nerve growth factor during liver injury: evidence for paracrine regulation of hepatic stellate cell apoptosis | Q42132079 | ||
| Induction of connective tissue growth factor by activation of heptahelical receptors. Modulation by Rho proteins and the actin cytoskeleton | Q42493036 | ||
| Connective tissue growth factor (CTGF/CCN2) in hepatic fibrosis | Q42600836 | ||
| Gliotoxin stimulates the apoptosis of human and rat hepatic stellate cells and enhances the resolution of liver fibrosis in rats | Q43720079 | ||
| Inhibition of apoptosis of activated hepatic stellate cells by tissue inhibitor of metalloproteinase-1 is mediated via effects on matrix metalloproteinase inhibition: implications for reversibility of liver fibrosis | Q43858122 | ||
| Serotonin is a novel survival factor of cardiomyocytes: mitochondria as a target of 5-HT2B receptor signaling | Q44435280 | ||
| Gliotoxin ameliorates development of fibrosis and cirrhosis in a thioacetamide rat model | Q44553035 | ||
| Hepatic microvascular regulatory mechanisms. XII. Effects of 5-HT2-receptor blockade on serotonin-induced intralobular hypoperfusion | Q45091566 | ||
| Relevance of mast cells and hepatic lobule innervation to liver injury | Q45095180 | ||
| Inhibition of inhibitor of kappaB kinases stimulates hepatic stellate cell apoptosis and accelerated recovery from rat liver fibrosis. | Q45212249 | ||
| Autocrine/paracrine regulation of the growth of the biliary tree by the neuroendocrine hormone serotonin. | Q45212253 | ||
| Antifibrogenic role of the cannabinoid receptor CB2 in the liver | Q46376137 | ||
| Transformation-dependent susceptibility of rat hepatic stellate cells to apoptosis induced by soluble Fas ligand | Q47720301 | ||
| Dominant-negative soluble PDGF-beta receptor inhibits hepatic stellate cell activation and attenuates liver fibrosis | Q47785420 | ||
| The role of the autonomic nervous system in chemically-induced liver damage and repair--using the essential hypertensive animal model (SHR). | Q49167137 | ||
| Evidence for a storage pool defect in platelets from cirrhotic patients with defective aggregation | Q61763141 | ||
| Platelet and plasma serotonin in patients with liver cirrhosis | Q69753867 | ||
| Ketanserin: a new perspective in posttransplant erythrocytosis? | Q71128124 | ||
| Serotonin regulation of gene expression in uterine extracellular matrix: reciprocal effects on collagens and collagenase | Q71594313 | ||
| Blood and plasma 5-hydroxytryptamine levels in patients with cirrhosis | Q71650336 | ||
| Anti-mitogenic effects of sarpogrelate in cultured rat mesangial cells | Q73167994 | ||
| Ileal carcinoid tumor complicating carcinoid heart disease and secondary retroperitoneal fibrosis | Q73884341 | ||
| Induction of DNA synthesis in primary cultures of rat hepatocytes by serotonin: possible involvement of serotonin S2 receptor | Q74027092 | ||
| Induction of serotonin transporter by hypoxia in pulmonary vascular smooth muscle cells. Relationship with the mitogenic action of serotonin | Q74452830 | ||
| Serotonin enhances the production of type IV collagen by human mesangial cells | Q77394383 | ||
| 5-Hydroxytryptamine2-family receptors (5-hydroxytryptamine2A, 5-hydroxytryptamine2B, 5-hydroxytryptamine2C): where structure meets function | Q77425309 | ||
| Serotonin 5-HT2A receptor induces TGF-beta1 expression in mesangial cells via ERK: proliferative and fibrotic signals | Q77855932 | ||
| Transforming growth factor beta and tumor necrosis factor alpha inhibit both apoptosis and proliferation of activated rat hepatic stellate cells | Q77933562 | ||
| Serotonin metabolism in rat mesangial cells: involvement of a serotonin transporter and monoamine oxidase A | Q93926657 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | serotonin | Q167934 |
| cell function | Q95674809 | ||
| P304 | page(s) | 861–876 | |
| P577 | publication date | 2006-09-01 | |
| P1433 | published in | The American Journal of Pathology | Q4744259 |
| P1476 | title | A role for serotonin (5-HT) in hepatic stellate cell function and liver fibrosis | |
| P478 | volume | 169 |
| Q39202142 | 5-HT2A receptor antagonists inhibit hepatic stellate cell activation and facilitate apoptosis |
| Q40422880 | 5-Hydroxytryptamine promotes hepatocellular carcinoma proliferation by influencing β-catenin |
| Q33414941 | A Preliminary Study on the Relationship between Platelet Serotonin Transporter Functionality, Depression, and Fatigue in Patients with Untreated Chronic Hepatitis C. |
| Q90351405 | Accumulation of myeloid lineage cells is mapping out liver fibrosis post injury: a targetable lesion using Ketanserin |
| Q41167772 | Activated hepatic stellate cells: negative regulators of hepatocyte proliferation in liver diseases |
| Q28476430 | Activation of protein serine/threonine phosphatase PP2Cα efficiently prevents liver fibrosis |
| Q37353099 | Advances in antifibrotic therapy |
| Q36919731 | Biogenic amine actions on cholangiocyte function |
| Q37175438 | Cholangiocyte proliferation and liver fibrosis. |
| Q26825671 | Chronic hepatitis C and liver fibrosis. |
| Q28078684 | Clinical Advancements in the Targeted Therapies against Liver Fibrosis. |
| Q56530996 | Coalescing beneficial host and deleterious antiparasitic actions as an antischistosomal strategy |
| Q42022563 | Connective tissue growth factor in tumor pathogenesis. |
| Q38364957 | Current frontiers in systemic sclerosis pathogenesis. |
| Q30473375 | Current status of novel antifibrotic therapies in patients with chronic liver disease |
| Q38896063 | Development of resistance to serotonin-induced itch in bile duct ligated mice |
| Q35460340 | Effect of 5-HT7 receptor blockade on liver regeneration after 60-70% partial hepatectomy. |
| Q42703981 | Effect of Gestational Exposure of Cypermethrin on Postnatal Development of Brain Cytochrome P450 2D1 and 3A1 and Neurotransmitter Receptors |
| Q38642487 | Enteric Serotonin and Oxytocin: Endogenous Regulation of Severity in a Murine Model of Necrotizing Enterocolitis |
| Q34066972 | Expression of p53 in the effects of artesunate on induction of apoptosis and inhibition of proliferation in rat primary hepatic stellate cells |
| Q34658528 | Fibrosis and carcinoid syndrome: from causation to future therapy |
| Q53581215 | Hepatic fibrosis 2006: report of the Third AASLD Single Topic Conference. |
| Q35124593 | Hepatic stellate cells and astrocytes: Stars of scar formation and tissue repair |
| Q29616840 | Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver |
| Q27310913 | Identification of Chemical Inhibitors of β-Catenin-Driven Liver Tumorigenesis in Zebrafish |
| Q87669646 | Liver fibrosis |
| Q33395901 | Liver regeneration is promoted by increasing serotonin content in rat liver with secondary biliary cirrhosis |
| Q37865859 | Mechanisms of hepatic fibrogenesis |
| Q39294420 | Mechanisms of hepatic stellate cell activation |
| Q92174629 | Modulation of the Tryptophan Hydroxylase 1/Monoamine Oxidase-A/5-Hydroxytryptamine/5-Hydroxytryptamine Receptor 2A/2B/2C Axis Regulates Biliary Proliferation and Liver Fibrosis During Cholestasis |
| Q41953936 | Nerve-cancer interactions in the stromal biology of pancreatic cancer |
| Q41564524 | Peripheral serotonin regulates postoperative intra-abdominal adhesion formation in mice |
| Q34973681 | Platelet-derived serotonin links vascular disease and tissue fibrosis |
| Q92081687 | Platelets as Key Factors in Hepatocellular Carcinoma |
| Q28071893 | Platelets: No longer bystanders in liver disease |
| Q49168017 | Post-Resection Exhaustion of Intra-Platelet Serotonin: Also an Indicator of Early Hepatocellular Carcinoma Recurrence? |
| Q21134750 | Reduced serotonin reuptake transporter (SERT) function causes insulin resistance and hepatic steatosis independent of food intake |
| Q92354635 | Role of 5-HT7 receptors in the immune system in health and disease |
| Q33344424 | Role of iron in hepatic fibrosis: one piece in the puzzle |
| Q34450683 | Role of serotonin in development of esophageal and gastric fundal varices |
| Q33645106 | Role of serotonin in fatty acid-induced non-alcoholic fatty liver disease in mice |
| Q97545426 | Selective serotonin reuptake inhibitors (SSRIs) prevent meta-iodobenzylguanidine (MIBG) uptake in platelets without affecting neuroblastoma tumor uptake |
| Q47133468 | Selective serotonin reuptake inhibitors and the risk of hepatocellular carcinoma in hepatitis B virus-infected patients |
| Q55024386 | Serotonin Exhibits Accelerated Bleomycin-Induced Pulmonary Fibrosis through TPH1 Knockout Mouse Experiments. |
| Q43122702 | Serotonin deficiency exacerbates acetaminophen-induced liver toxicity in mice |
| Q85830341 | Serotonin in liver tumor: Friend or foe? |
| Q38049023 | Serotonin paracrine signaling in tissue fibrosis |
| Q36697797 | Serotonin promotes the proliferation of serum-deprived hepatocellular carcinoma cells via upregulation of FOXO3a. |
| Q24297176 | Serotonin promotes tumor growth in human hepatocellular cancer |
| Q24610679 | Stimulating healthy tissue regeneration by targeting the 5-HT₂B receptor in chronic liver disease |
| Q34487150 | Switching-on of serotonergic calcium signaling in activated hepatic stellate cells. |
| Q42591676 | Targeting liver myofibroblasts: a novel approach in anti-fibrogenic therapy. |
| Q52690372 | The Role of Serotonin during Skin Healing in Post-Thermal Injury. |
| Q46429020 | The effect of terguride in carbon tetrachloride-induced liver fibrosis in rat. |
| Q33617543 | The serotonin 5-HT2B receptor controls bone mass via osteoblast recruitment and proliferation |
| Q34977162 | Trazodone generates m-CPP: in 2008 risks from m-CPP might outweigh benefits of trazodone |
| Q90355553 | Tryptophan metabolites kynurenine and serotonin regulate fibroblast activation and fibrosis |
| Q37149500 | Wound healing and local neuroendocrine regulation in the injured liver. |
Search more.